Infant Feeding Practice and Gut Comfort Study

October 2, 2023 updated by: Société des Produits Nestlé (SPN)

Infant Feeding Practice and Gut Comfort: a Multi-country, Cross-sectional Observational Study

Multi-country, cross-sectional, observational study in diverse geographic locations all over the world.

Study Overview

Status

Completed

Conditions

Detailed Description

This is a cross-sectional single time point study. Infants and caregivers who come to a clinic for a routine health visit who wish to participate in the study by signing the consent form and meet all inclusion criteria/exclusion criteria will be enrolled.

At the visit, a research staff member will assist the parents to complete (i) Feeding Practice and Gut Comfort Questionnaire and (ii) Infant Gastrointestinal Symptom (IGSQ)-13 items. Additionally, infant's anthropometrics (weight, length, head circumference) will be recorded. These anthropometrics will be measured by the researcher as part of the routine visit.

Study Type

Observational

Enrollment (Actual)

2804

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Alexandria, Egypt
        • Alexandria University
      • Assiut, Egypt
        • Assuit University
      • Cairo, Egypt
        • Cairo University
      • Cairo, Egypt
        • Ain Shams University
      • Tanta, Egypt
        • Tanta University
      • Zagazig, Egypt
        • Zagazig University
      • Chennai, India
        • Apollo Children's Hospital
      • Kolkata, India
        • ICH Hospital
      • Thāne, India
        • Dr Praveen Gokhales Childrens Clinic and Vaccination Centre
      • Yogyakarta, Indonesia
        • Faculty of Medicine Universitas Gadjah Mada
      • Kuala Lumpur, Malaysia, 50603
        • University of Malaya
      • Islamabad, Pakistan
        • PIMS
      • Karachi, Pakistan
        • National Institute of Child Health
      • Lahore, Pakistan
        • The Children Hospital & Institute of Child Health
      • Rawalpindi, Pakistan
        • BBH
      • Quezon City, Philippines, 1112
        • St.Luke'S College of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 4 months (Child)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Healthy normal developing male and female full-term infants

Description

Inclusion Criteria:

  • Healthy full term (37-42 weeks of gestation) singleton infant.
  • Postnatal age ≥ 6 weeks and ≤ 4 months
  • Parent as primary Caregiver and ≥ 18 years old
  • Exclusively/predominantly breastfeeding or exclusively/predominantly formula feeding of the same type/brand, for at least the past 2 weeks.
  • Evidence of personally signed and dated informed consent document by the infant's parent(s).

Exclusion Criteria:

  • Chronic illness necessitating medical follow up
  • Acute ongoing or recent (last 2 weeks) illness necessitating medical follow up
  • Any known case of food allergy (e.g milk)
  • Caregivers who are not likely to comply with the study procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Exclusively/predominantly Breastfeeding group
There is no intervention in this observational study.
Exclusively/predominantly Formula feeding group
There is no intervention in this observational study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
An index score of overall GI symptom burden
Time Frame: single time point between 6 weeks to 4 months
Measured by Validated, standardized infant Gastrointestinal Symptom Questionnaire (IGSQ-13)
single time point between 6 weeks to 4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
GI Symptoms
Time Frame: single time point between 6 weeks to 4 months
measured by IGSQ-13 questionnaires (An overall index score is calculated from 13 questions in the questionnaire as a measure of total GI symptom burden. The values for the IGSQ index score can range from 13 (low GI burden) to 65 (high GI burden))
single time point between 6 weeks to 4 months
Stool characteristics
Time Frame: one day recall before study visit
measured by Feeding Practice and Gut Comfort Questionnaire (frequency and consistency)
one day recall before study visit
Physician-reported and parent-reported Colic
Time Frame: Single time point between 6 weeks to 4 months
measured by Feeding Practice and Gut Comfort Questionnaire based on ROME IV diagnosis criteria. Effect of feeding group on the prevalence of colic will be assessed by logistic regression.
Single time point between 6 weeks to 4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Yvan Vandenplas, Universitair Ziekenhuis Brussel

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 9, 2018

Primary Completion (Actual)

December 30, 2019

Study Completion (Actual)

December 31, 2019

Study Registration Dates

First Submitted

October 4, 2018

First Submitted That Met QC Criteria

October 11, 2018

First Posted (Actual)

October 12, 2018

Study Record Updates

Last Update Posted (Actual)

October 4, 2023

Last Update Submitted That Met QC Criteria

October 2, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 17.12.INF

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Infants

Clinical Trials on There is no intervention in this observational study.

3
Subscribe